Latest Breaking News On - Hans van dongen - Page 1 : comparemela.com

Axsome Therapeutics Highlights Data on Solriamfetol Demonstrating Improvement in Cognitive Function in Patients with Obstructive Sleep Apnea or Narcolepsy at SLEEP 2024

Axsome Therapeutics, Inc. , a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced five presentations, including two featured oral plenary presentations, on.

Axsome to Present Findings on Solriamfetol's Cognitive Benefits

Axsome will unveil data demonstrating solriamfetol's ability to enhance cognitive functioning in patients with OSA and narcolepsy.

How Does the Night Shift Impact Metabolic Health?

Brief stint of night shift work may contribute to the development of chronic metabolic conditions.

Study shows how working night shift can quickly

A new study shows evidence of how fast the graveyard shift works can impact your body and health.

Study shows how night shift work can raise risk of diabetes, obesity